Press release
U.S. Beauty Devices Market with Global Key Companies Profile, Demand and Cost Structure
The market is mainly driven by growing geriatric population, rising prevalence of skin diseases and hair loss, and increasing healthcare expenditure.Based on type of device, the beauty devices market in the U.S. is categorized into hair removal, cleansing, acne, light/LED therapy and photorejuvenation, oxygen and steamer, hair growth, dermal rollers, cellulite reduction, and other devices. The market for hair removal devices is predicted to reach $7.9 billion by 2023, registering a CAGR of 18.8% during the forecast period. Hair removal devices are used to remove and reduce unwanted hair painlessly, without damaging the surrounding skin. In some devices, laser is also used which produces enough heat to destroy hair, thus providing long-lasting results lead to increased demand for these devices.
Request to Get the Sample Pages at:
https://www.psmarketresearch.com/market-analysis/us-beauty-devices-market/report-sample
The easy availability of various beauty products and devices for hair removal, acne reduction, and skin rejuvenation is making the U.S. population more inclined to opt for portable, easy-to-use, and convenient at-home beauty devices.
Make Enquiry Before Buying the Report:
https://www.psmarketresearch.com/send-enquiry?enquiry-url=us-beauty-devices-market
In order to increase their market share, key players in the beauty devices industry of the U.S. are acquiring other companies operating in the domain. For instance, in May 2018, L'Oral SA (L'Oral) announced 100% acquisition of Nanda Co. Ltd., a Korean lifestyle make-up and fashion company. With this acquisition, L'Oral plans to expand the sales of its 3CE cosmetics brand, internationally. The company expects to complete the transaction in two months, after receiving customary regulatory approvals.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Beauty Devices Market with Global Key Companies Profile, Demand and Cost Structure here
News-ID: 2003353 • Views: …
More Releases from P&S Intelligence
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media.
In order to pace up the 4th industrial revolution, businesses across various industries…
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG.
North America will grow the fastest with a rate of 10.5% in…
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use.
Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls…
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities…
More Releases for Oral
Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lympho …
"The Report Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC…
Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi …
"The Report Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4)-The histamine H4 receptor is a member of the…
Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsph …
"The Report Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
According to the recently published report Glucosylceramidase-Pipeline Review, H2 2017; Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase…
Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo …
"The Report Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5)-Aldosterone synthase…
Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or …
ReportsWorldwide has announced the addition of a new report title Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
According to the recently published report 'Neutrophil Elastase - Pipeline Review, H2 2017'; Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin…
Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp16 …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Glutamyl Aminopeptidase Pipeline Review, H2 2017”, report provides Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC 3.4.11.7) pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies. The latest report Glutamyl Aminopeptidase - Pipeline Review, H2…
